The company is an intensive outpatient programs (IOP) focused on addiction treatments. The company offers day treatment, group therapy, one-on-one counseling, case management, and structured residential housing.

Key Aspects

Revenue grew at a compound annual growth rate (CAGR) of 119.2% from 2019 through 2022
Achieved an adjusted EBITDA margin of 28.6% from 2021 through 2022
The company accepts out-of-state patients
Residents and non-residents can utilize all services offered
IOP services are immediate and have no wait times
Company staff is composed of expert licensed therapists
Licensed with several large insurance companies and Medicaid.

Opportunities

Expand service offerings and hours of operation to reach more potential patients
Bring medical billing in-house to reduce expenses
Increase marketing to out-of-state clinical stabilization services (CSS) and hospitals to reach more potential patients

Headquartered

Northeast, US

Real Estate

The company operates from three day treatment facilities and seven structured residential houses. Two treatment facilities and seven homes are owned by an affiliated entity, which is expected to be included in the sale. The third treatment facility is leased from an unrelated third party.

Shareholder Objectives

The company is fully owned by a single shareholder who is seeking an exit strategy. He is willing to remain with the company for a predetermined period to facilitate a smooth transition to new ownership.

Benchmark International

Benchmarks Exclusive Opportunities

Outpatient Recovery Program and Structured Residential Housing – BN000045374

Outpatient Recovery Program and Structured Residential Housing – BN000045374

Login